Lipid treatment status and goal attainment among patients with atherosclerotic cardiovascular disease in the United States: A 2019 update-Reference-Cited by-同舟云学术

Lipid treatment status and goal attainment among patients with atherosclerotic cardiovascular disease in the United States: A 2019 update

Published:2022-06 Issue: Volume:10 Page:100336
ISSN:2666-6677
Container-title:American Journal of Preventive Cardiology
language:en
Short-container-title:American Journal of Preventive Cardiology

Author:

Gu Jing^ORCID,Sanchez Robert J.,Chauhan Ankita,Fazio Sergio,Wong Nathan D.

Funder

Regeneron Pharmaceuticals

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. Centers for Disease Control and Prevention. Heart Disease Facts. https://www.cdc.gov/heartdisease/facts.htm. Published 2021. Updated 09/27/2021. Accessed 11/08/2021.

2. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials;Mihaylova;Lancet,2012

3. Alirocumab and cardiovascular outcomes after acute coronary syndrome;Schwartz;New England J Med,2018

4. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events;Sabatine;New England J Med,2015

5. Simulation of lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular disease;Cannon;JAMA Cardiol,2017

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender disparities in utilization of statins for low density lipoprotein management across the spectrum of atherosclerotic cardiovascular disease: Insights from the houston methodist cardiovascular disease learning health system registry;American Journal of Preventive Cardiology;2024-09

2. Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications;American Journal of Cardiovascular Drugs;2024-08-13

3. Physician preferences for treatment of low-density lipoprotein cholesterol among patients with atherosclerotic cardiovascular disease (ASCVD)–A discrete choice experiment;Heliyon;2024-08

4. Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease;Mayo Clinic Proceedings;2024-08

5. Sex Differences in Low-Density Lipoprotein Cholesterol Treatment Among Young Israeli Patients Following Premature Acute Coronary Syndrome;Metabolic Syndrome and Related Disorders;2024-08-01